(Q79218010)
English
A phase I/randomized phase II, non-comparative, multicenter, open label trial of CP-547,632 in combination with paclitaxel and carboplatin or paclitaxel and carboplatin alone as first-line treatment for advanced non-small cell lung cancer (NSCLC)
scientific article published on 10 October 2006
Statements
A phase I/randomized phase II, non-comparative, multicenter, open label trial of CP-547,632 in combination with paclitaxel and carboplatin or paclitaxel and carboplatin alone as first-line treatment for advanced non-small cell lung cancer (NSCLC) (English)
Roger B Cohen
Corey J Langer
George Rajan Simon
Peter David Eisenberg
John Daniel Hainsworth
Stefan Madajewicz
Thomas Michael Cosgriff
Kristen Pierce
Huiping Xu
Katherine Liau
10 October 2006